Wells Fargo & Company Dr Reddys Laboratories LTD Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Wells Fargo & Company holds 1,314 shares of RDY stock, worth $20,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,314

Previous 1,273 3.22%

Holding current value

$20,642

Previous $96,000 8.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$75.41 - $84.21 $3,091 - $3,452	41 Added 3.22%	1,314 $104,000
Q2 2024 Aug 13, 2024	SELL	$68.26 - $76.19 $98,772 - $110,246	-1,447 Reduced 53.2%	1,273 $96,000
Q1 2024 May 10, 2024	SELL	$67.36 - $77.59 $13,472 - $15,518	-200 Reduced 6.85%	2,720 $199,000
Q4 2023 Feb 09, 2024	BUY	$64.27 - $69.9 $771 - $838	12 Added 0.41%	2,920 $203,000
Q3 2023 Nov 13, 2023	SELL	$61.9 - $72.77 $9,656 - $11,352	-156 Reduced 5.09%	2,908 $194,000
Q2 2023 Aug 15, 2023	BUY	$53.34 - $63.11 $83,103 - $98,325	1,558 Added 103.45%	3,064 $193,000
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $20,600 - $22,715	399 Added 36.04%	1,506 $85,000
Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $3,836 - $4,308	-75 Reduced 6.35%	1,107 $57,000
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $9,880 - $11,349	-198 Reduced 14.35%	1,182 $62,000
Q2 2022 Aug 12, 2022	BUY	$49.62 - $58.13 $10,122 - $11,858	204 Added 17.35%	1,380 $76,000
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $7,288 - $9,852	151 Added 14.73%	1,176 $66,000
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $4.31 Million - $4.87 Million	-72,449 Reduced 98.6%	1,025 $67,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $2.24 Million - $2.81 Million	-37,298 Reduced 33.67%	73,474 $4.79 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $816,940 - $975,804	-13,151 Reduced 10.61%	110,772 $8.14 Million
Q1 2021 May 13, 2021	BUY	$57.98 - $73.08 $3.37 Million - $4.25 Million	58,157 Added 88.43%	123,923 $7.61 Million
Q4 2020 Feb 09, 2021	SELL	$62.61 - $71.29 $1.68 Million - $1.91 Million	-26,819 Reduced 28.97%	65,766 $4.69 Million
Q3 2020 Nov 05, 2020	SELL	$51.39 - $72.41 $995,270 - $1.4 Million	-19,367 Reduced 17.3%	92,585 $6.44 Million
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $1.55 Million - $2.14 Million	-39,182 Reduced 25.93%	111,952 $5.94 Million
Q1 2020 May 14, 2020	BUY	$34.75 - $45.85 $5.25 Million - $6.93 Million	151,134 New	151,134 $6.1 Million

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.61B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Dr Reddys Laboratories LTD Transaction History